{"organizations": [], "uuid": "b67275af49a00091f4d70dcdcb650929c2a18853", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 21, "shares": 21, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-4744/social", "site_section": "http://online.wsj.com/xml/rss/3_7455.xml", "section_title": "WSJ.com: WSJD", "url": "https://www.wsj.com/articles/no-revenue-no-problemhong-kong-draws-biotech-firms-looking-to-list-1521713516", "country": "US", "domain_rank": 387, "title": "No Revenue? No Problem—Hong Kong Draws Biotech Firms Looking to List", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T13:11:00.000+02:00", "replies_count": 0, "uuid": "b67275af49a00091f4d70dcdcb650929c2a18853"}, "author": "Preetika Rana", "url": "https://www.wsj.com/articles/no-revenue-no-problemhong-kong-draws-biotech-firms-looking-to-list-1521713516", "ord_in_thread": 0, "title": "No Revenue? No Problem—Hong Kong Draws Biotech Firms Looking to List", "locations": [], "entities": {"persons": [], "locations": [{"name": "hong kong", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Hong Kong’s stock exchange is gearing up to allow biotechnology companies to sell shares before generating any revenue—and companies are preparing to rush in.\nDozens of early-stage drug makers and other biotech firms are planning to list in Hong Kong over the next two years, say executives, bankers and investors, as the exchange pushes through its biggest regulatory overhaul in decades.\nU.S.... ", "external_links": [], "published": "2018-03-22T13:11:00.000+02:00", "crawled": "2018-03-22T15:17:38.033+02:00", "highlightTitle": ""}